PELLICANO', Giovanni Francesco
 Distribuzione geografica
Continente #
EU - Europa 15.784
NA - Nord America 15.543
AS - Asia 8.836
SA - Sud America 3.154
Continente sconosciuto - Info sul continente non disponibili 1.606
AF - Africa 289
OC - Oceania 22
Totale 45.234
Nazione #
US - Stati Uniti d'America 15.139
RU - Federazione Russa 7.342
SG - Singapore 3.868
BR - Brasile 2.713
CN - Cina 2.252
IT - Italia 2.128
IE - Irlanda 1.780
SE - Svezia 1.385
HK - Hong Kong 1.019
DE - Germania 634
FR - Francia 585
PL - Polonia 553
VN - Vietnam 488
UA - Ucraina 367
GB - Regno Unito 283
FI - Finlandia 280
BD - Bangladesh 240
IN - India 211
CA - Canada 172
AR - Argentina 155
MX - Messico 109
AT - Austria 103
IQ - Iraq 103
TR - Turchia 93
ZA - Sudafrica 84
EC - Ecuador 78
NL - Olanda 77
ID - Indonesia 70
PK - Pakistan 64
CO - Colombia 60
ES - Italia 55
JP - Giappone 55
MA - Marocco 55
UZ - Uzbekistan 53
BE - Belgio 47
VE - Venezuela 45
MY - Malesia 34
SA - Arabia Saudita 32
CL - Cile 31
PY - Paraguay 25
JM - Giamaica 23
PH - Filippine 23
AE - Emirati Arabi Uniti 22
TN - Tunisia 22
JO - Giordania 21
CI - Costa d'Avorio 20
KE - Kenya 20
TH - Thailandia 20
UY - Uruguay 20
AU - Australia 19
CZ - Repubblica Ceca 19
PE - Perù 19
AZ - Azerbaigian 18
EG - Egitto 18
AL - Albania 17
DZ - Algeria 17
NP - Nepal 17
CR - Costa Rica 16
KR - Corea 16
LV - Lettonia 16
HN - Honduras 15
LT - Lituania 15
RO - Romania 14
KZ - Kazakistan 13
CH - Svizzera 12
GT - Guatemala 12
OM - Oman 12
PT - Portogallo 12
RS - Serbia 12
IR - Iran 11
KG - Kirghizistan 11
BG - Bulgaria 10
DO - Repubblica Dominicana 10
ET - Etiopia 10
SN - Senegal 10
TT - Trinidad e Tobago 10
EU - Europa 8
IL - Israele 8
SV - El Salvador 8
BH - Bahrain 7
BO - Bolivia 7
LB - Libano 7
PA - Panama 7
GE - Georgia 6
NI - Nicaragua 6
PR - Porto Rico 6
DK - Danimarca 5
GR - Grecia 5
LK - Sri Lanka 5
NG - Nigeria 5
NO - Norvegia 5
PS - Palestinian Territory 5
AM - Armenia 4
AO - Angola 4
BF - Burkina Faso 4
BY - Bielorussia 4
GH - Ghana 4
LA - Repubblica Popolare Democratica del Laos 4
MD - Moldavia 4
SY - Repubblica araba siriana 4
Totale 43.571
Città #
Moscow 2.250
Ashburn 2.135
Singapore 2.086
Dublin 1.774
Dallas 1.633
Chandler 1.387
Hong Kong 1.016
Jacksonville 877
San Jose 850
Nyköping 758
Beijing 753
Council Bluffs 541
Warsaw 536
Princeton 435
Dearborn 416
Messina 395
The Dalles 336
Los Angeles 320
Lauterbourg 315
Des Moines 271
Medford 258
New York 239
Ann Arbor 226
São Paulo 197
Boardman 164
Buffalo 156
Cambridge 154
Munich 148
Ho Chi Minh City 142
Rome 135
Redondo Beach 128
Santa Clara 122
Milan 120
Palermo 104
Guangzhou 103
Wilmington 103
Hanoi 90
Jinan 89
Dong Ket 85
Tianjin 84
Rio de Janeiro 82
Frankfurt am Main 80
Orem 79
Helsinki 76
Nuremberg 75
Catania 73
Houston 72
San Mateo 65
Belo Horizonte 64
Woodbridge 61
Brooklyn 57
Atlanta 56
Nanjing 54
Shenyang 54
Brasília 53
Lancaster 53
Vienna 53
Tashkent 50
Turku 49
Curitiba 47
Tokyo 47
Brussels 46
Pune 44
Baghdad 43
Seattle 43
Bremen 42
Phoenix 42
Chicago 39
Johannesburg 39
Montreal 39
Naples 39
Shanghai 39
Chennai 38
Porto Alegre 38
Columbus 37
Shenzhen 37
San Francisco 36
Denver 35
Mexico City 35
Toronto 34
Amsterdam 33
Philadelphia 32
Manchester 31
Jakarta 30
Zhengzhou 30
Hebei 29
Ningbo 28
Ottawa 28
Goiânia 27
Haikou 27
London 27
Boston 26
Campinas 26
Guayaquil 26
Guarulhos 25
Hangzhou 25
Ribeirão Preto 25
Caltagirone 24
Norwalk 24
Salvador 24
Totale 24.523
Nome #
Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen 471
Awareness and perception of accurancy of the Undetectable=Untransmittable (U=U) message in people living with HIV/AIDS (PLWHA), in Italy and correlation with the level of confidence in reference physicians. 335
Durability of F/TAF-based regimens in a large cohort of PLWH seen of care in Italy 289
Wasting Syndrome (cachessia da HIV) in paziente confetto HBV-HCV 281
Impact of multi-drug resistance on mortality: a multi-cohort Italian study. 280
Anal cancer in people living with HIV: the importance of the screening and of early diagnosis 274
Breast cancer in women living with HIV 260
“Indulto” e co-infezione HIV-HCV: Caso Clinico 224
Bioenergetics of T Cell Activation and Death in HIV Type 1 Infection 220
AIDS E SISTEMA NERVOSO CENTRALE NEL PAZIENTE ADVANCED-NAÏVE 219
Evaluation of HIV transmission cluster among natives and foreigners living Italy 217
SINDROME INFIAMMATORIA DA IMMUNORICOSTITUZIONE (IRIS) 208
MALATTIE INFETTIVE E TROPICALI PER STUDENTI E MEDICI DI MEDICINA GENERALE 206
Bone disease in HIV infection: an overview of pathogenesis, clinical manifestations and treatment 206
Hepatitis C-related hepatocellular carcinoma: diagnostic and therapeutic management in HIV-patients. 202
Bacteremic meningitis due to Pasteurella multocida resistant to first line antibiotic therapy 202
Sindrome Retrovirale Acuta (SRA) in giovane omosessuale maschio 200
QUANTO I GIOVANI DELLA CITTA’ DI MESSINA CONOSCONO L’HIV/AIDS E LE MALATTIE SESSUALMENTE TRASMESSE? 200
Danno ipossico in linfociti T periferici di soggetti affetti da HIV/AIDS. 199
Anxiety disorders and adherence to HAART 198
Sinus bradycardia in a patient with bacterial meningitis in therapy with IVIg: a case report 198
Alterazioni della membrana plasmatica in linfociti del sangue periferico di soggetti affetti da infezione da HIV/AIDS 195
An evaluation of the burden of invasive Enterococcal infection in a large university hospital 195
Carbon nanotubes and central nervous system: Environmental risks, toxicological aspects and future perspectives 193
La vaccinazione del soggetto HIV+: l’esperienza di una Azienda Ospedaliera Universitaria del Sud Italia 193
Epidemiologia delle farmacoresistenze di HIV nella regione Sicilia 193
DANNO IPOSSICO IN LINFOCITI T CIRCOLANTI DI PAZIENTI HIV+: RUOLO DELLA FIBROSI LINFONODALE. 190
Circulating angiopoietin‑like protein 2 levels are associated with decreased renal function in HIV+ subjects on cART: A potential marker of kidney disease 190
Sindrome di Castelman in paziente affetto da HIV e con sospetto Sarcoma di Kaposi. 190
Impact of the COVID-19 pandemic on HPV vaccination coverage in the general population and in PLWHs 189
Knowledge of sexually transmitted infections and risky behaviours: a survey among high school and university students 188
Kaposi’s sarcoma in HIV-infected patients in the era of new antiretrovirals 187
Intracellular accumulation of cell cycle regulatory proteins and nucleolin re-localization are associated with pre-lethal ultrastructural lesions in circulating T lymphocytesThe HIV-induced cell cycle dysregulation revisited 187
Cancer screening in HIV-infected patients: early diagnosis in a high-risk population 187
APPLICAZIONI INNOVATIVE PER LA DIAGNOSTICA DELL'INFEZIONE DA HIV 186
Assistenza alla persona con HIV/AIDS 186
Management care improvement of people living with HIV: Definition of a targeted clinical pathway in a university hospital of south Italy 186
La terapia della brucellosi cronica con ciprofloxacina. Esperienze personali 184
Nucleolin relocalization associated top re-lethal alterations of T cell morphology: redefining death in HIV infection 184
Efficacy of COVID-19 Vaccination in People Living with HIV: A Public Health Fundamental Tool for the Protection of Patients and the Correct Management of Infection 182
Transmission mode associated with coronavirus disease 2019: a review 182
Real-life efficacy and satisfaction of long-acting ART CabotegravirRilpivirine in HIV-infected individuals 181
48 Week efficacy of first line antiretroviral treatments for hiv infection in 1998 and 2006: preliminary results of a multicentric investigation 180
DISFUNZIONE MITOCONDRIALE IN LINFOCITI T CIRCOLANTI DI PAZIENTI HIV+. 180
A proposito di una osservazione di sindrome di Loffler in corso di ascaridiasi 179
ASSISTENZA ALLA PERSONA CON DISTURBI IMMUNO-MEDIATI 179
Acute pericarditis during early-diagnosed Brucellosis: a case report. 179
Aspetti clinico-epidemiologici della spondilodiscite brucellare 178
HIV and Colorectal Cancer. New Insights and Review of the Literature 177
Kaposi’s Sarcoma and Psoriasis in a naïve HIV-positive patient: a case report 177
Malignant melanoma in HIV: epidemiology, pathogenesis and management 175
Non-AIDS defining cancers: a comprehensive update on diagnosis and management 174
Epidemiologia delle farmacoresistenza di HIV nella Regione Sicilia. 173
DANNO IPOSSICO IN LINFOCITI T PERIFERICI DI SOGGETTI AFFETTI DA HIV/AIDS. 172
MASSIVA MORTE APOPTOTICA DI LINFOCITI T NEL SANGUE PERIFERICO DI SOGGETTI INFETTI DA HIV: CONSEGUENZE PATOLOGICO-CLINICHE 172
96 Week Follow-Up of HIV-Infected Patients in Rescuewith Raltegravir Plus Optimized Backbone Regimens: A Multicentre Italian Experience 171
A proposito della immunoterapia attiva nella Brucellosi Cronica 170
Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudina/Dolutegravir Therapy in Human Immunodeficiency Virus Treatment-Experienced Patients. 170
19. Nostre esperienze con ciprofloxacina nella terapia della brucellosi acuta 169
HCV elimination in persons living with HIV (PLWH): the NoCo (No Coinfection) study of the ICONA network 168
Prostate cancer in HIV-positive patients: a review of the literature 168
FARMACORESISTENZE E LORO CORRELAZIONI IN PAZIENTI HIV-1+ 163
Pseudomonas aeruginosa detection in South Italy: an epidemiological survey 161
Epatite A: immunità e accettazione della profilassi vaccinale in una coorte siciliana di pazienti con infezione da HIV. Dati preliminari. 161
La terza età della terapia antiretrovirale di combinazione 160
Bone marrow biopsy findings in brucellosis patients with hematologic abnormalities: useful remarks. 160
HIV and Mediterranean Zoonoses: A Review of the Literature 158
Loco-Regional Treatments for Hepatocellular Carcinoma in People Living with HIV 157
La patologia intestinale e ruolo di Giardia Lamblia in soggetti HIV+ 156
Nuovi regimi di terapia: l’utilizzo rationale di nuovi farmaci e nuove strategie (regimi nuk-sparing) 156
AIDS Dementia Complex in paziente Advanced Naïve 155
Outbreak of Brucella melitensis infection in Eastern Sicily: risk factors, clinical characteristics and complication rate 155
IL TENOFOVIR NELLA TERAPIA ANTIRETROVIRALE: OSSERVAZIONI SULLA POSSIBILE NEFROTOSSICITA' DEL FARMACO 154
Effect of past virological failure on Dolutegravir+Lamivudine as maintenance regimen 154
Neurotoxoplasmosi in soggetto HIV positivo “advanced naive”. Segnalazione di caso clinico 153
Sexual dysfunction and anxiety in HIV-1-infected males in Eastern Sicily. 152
Physician attitudes and perceptions of complementary and alternative medicine (CAM): a multicentre italian study. 152
1605. Dual Therapy VS Triple Therapy in Experienced PLWH: a Multicentre One-Year Long Observational Study 151
Massiva morte apoptotica di linfociti T nel sangue periferico di soggetti infetti da HIV: conseguenze patologico-cliniche 151
FARMACOGENETICA NELLA PRATICA CLINICA IN UNA POPOLAZIONE SICILIANA HIV+ 151
Safety and tolerability of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project 151
Pulmonary Kaposi Sarcoma without Respiratory Symptoms and Skin Lesions in an HIV-Naïve Patient: A Case Report and Literature Review 151
Encefalopatia latente in corso di cirrosi alcoolica 150
Current fast methods for the identification of carbapenemase enzymes in clinical laboratory. 150
Epidemiology of Klebsiella pneumoniae MDR during the years 2015-2017 in “G. Martino” University Hospital of Messina: preliminary data. 150
Factors Associated With Weight Gain in People Treated With Dolutegravir 147
Epidemiology of the new HIV infections in a large university hospital of Southern Italy: the importance of increasing the culture of the HIV screening test in the prevention of late diagnosis 147
How Much Does HIV Positivity Affect the Presence of Oral HPV? A Molecular Epidemiology Survey 147
Analisis of efficacy and tolerability of raltegravir based regimens by background therapy in salvage: a Mulcicentre Italian Experience. 146
New and old assumptions of lung cancer in people living with HIV 145
Treatment of chronic brucellosis with ciprofloxacin. Personal experience 143
Definition of a novel vaccination pathway in PLWHA: experience of a Southern University Hospital 143
CASO CLINICO: PAZIENTE HIV/HCV e “INDULTO” 142
Proposal of model for personalized early adapted cancer screening in people living with HIV: experience of "Gaetano Martino" Hospital University of Messina 140
Cytomegalovirus complicating Inflammatory Bowel Disease: Useful Remarks. 140
Cervical cancer in women living with HIV: A review of the literature 139
Are HIV/HCV co.infected patients more likely to experience multiple lines of ART than HIV mono-infected patients? Results from the ICONA Foundation Study. 139
Comparative neuropsychiatric toxicity profile of dolutegravir versus efavirenz versus other antiretroviral third drugs used either in first-line or switching antiretroviral therapies (ART): data from ICONA Foundation Study Cohort 139
La patologia intestinale e ruolo di Giardia Lamblia in soggetti HIV+. 138
1986. Switching to DOR/3TC/TDF Improves Renal Function and Decreases Lipid Levels in People Living With HIV: a Real-Life Multicentric Study 137
Totale 18.192
Categoria #
all - tutte 150.249
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 150.249


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.933 0 0 44 104 145 42 101 106 54 209 257 871
2022/20235.767 776 388 223 469 423 558 115 329 2.169 39 201 77
2023/20241.475 149 201 120 170 96 287 39 72 24 68 51 198
2024/20257.707 111 106 164 477 625 190 185 1.592 1.977 434 610 1.236
2025/202619.871 844 1.415 1.757 1.347 1.435 4.199 2.568 2.223 2.187 1.000 361 535
2026/20272.148 395 1.199 554 0 0 0 0 0 0 0 0 0
Totale 45.234